Lundbeck encourages migraine patients to ‘Say Yep’ to its IV-infused med in latest campaign
19 Jan 2024
Lundbeck is taking a new tack in its migraine marketing for Vyepti, the only IV-infused option in the crowded market. The campaign, launched this week, reinforces the brand name with a “Say Yep” reminder and not having to worry about daily migraine management.
The TV ad uses over-the-top characters — an annoying co-worker, a school PTA leader, and a restaurant server — to loudly point out daily struggles to a young woman making her way through her day. The co-worker, for instance, flashes a giant cheesy grin and plunks a huge folder on her desk, saying “Who’s excited to work around the clock and do way too much managing migraine?”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.